Susquehanna International Group
ABMD

Susquehanna International Group’s Abiomed Inc ABMD Stock Holding History

Susquehanna International Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-971
Closed -$239K – 14358
2022
Q3 		$239K Sell
971
-7,662
-89% -$2.07M ﹤0.01% 10398
2022
Q2 		$2.14M Sell
8,633
-2,599
-23% -$701K ﹤0.01% 4780
2022
Q1 		$3.72M Sell
11,232
-598
-5% -$184K ﹤0.01% 4220
2021
Q4 		$4.25M Buy
11,830
+2,087
+21% +$705K ﹤0.01% 4026
2021
Q3 		$3.17M Sell
9,743
-11,100
-53% -$3.76M ﹤0.01% 4835
2021
Q2 		$6.5M Buy
20,843
+15,326
+278% +$4.7M ﹤0.01% 3559
2021
Q1 		$1.76M Buy
5,517
+1,429
+35% +$457K ﹤0.01% 6237
2020
Q4 		$1.32M Buy
4,088
+3,302
+420% +$913K ﹤0.01% 6026
2020
Q3 		$218K Sell
786
-5,020
-86% -$1.45M ﹤0.01% 9321
2020
Q2 		$1.4M Sell
5,806
-74,567
-93% -$15M ﹤0.01% 5169
2020
Q1 		$11.7M Sell
80,373
-64,518
-45% -$10.7M ﹤0.01% 1586
2019
Q4 		$24.7M Buy
144,891
+51,702
+55% +$9.59M 0.01% 1243
2019
Q3 		$16.6M Buy
93,189
+35,244
+61% +$7.62M 0.01% 1487
2019
Q2 		$15.1M Buy
57,945
+935
+2% +$248K 0.01% 1516
2019
Q1 		$16.3M Buy
+57,010
New +$18.9M 0.01% 1338
2018
Q4 		– Sell
-53,914
Closed -$18.7M – 10285
2018
Q3 		$24.2M Sell
53,914
-19,178
-26% -$7.56M 0.01% 1176
2018
Q2 		$29.9M Buy
73,092
+62,799
+610% +$22.8M 0.01% 994
2018
Q1 		$3M Sell
10,293
-10,746
-51% -$2.72M ﹤0.01% 3260
2017
Q4 		$3.94M Buy
21,039
+16,579
+372% +$3.1M ﹤0.01% 2844
2017
Q3 		$752K Sell
4,460
-10,923
-71% -$1.65M ﹤0.01% 5797
2017
Q2 		$2.2M Sell
15,383
-27,840
-64% -$3.74M ﹤0.01% 3748
2017
Q1 		$5.41M Buy
43,223
+35,909
+491% +$4.16M ﹤0.01% 2281
2016
Q4 		$824K Sell
7,314
-13,793
-65% -$1.6M ﹤0.01% 5938
2016
Q3 		$2.71M Sell
21,107
-31,892
-60% -$3.82M ﹤0.01% 3060
2016
Q2 		$5.79M Buy
52,999
+19,609
+59% +$1.95M ﹤0.01% 2023
2016
Q1 		$3.17M Sell
33,390
-1,287
-4% -$109K ﹤0.01% 2976
2015
Q4 		$3.13M Buy
34,677
+3,928
+13% +$333K ﹤0.01% 3206
2015
Q3 		$2.85M Sell
30,749
-24,306
-44% -$2.14M ﹤0.01% 3593
2015
Q2 		$3.62M Buy
55,055
+6,240
+13% +$415K ﹤0.01% 3511
2015
Q1 		$3.49M Buy
48,815
+38,564
+376% +$2.09M ﹤0.01% 3284
2014
Q4 		$390K Buy
+10,251
New +$323K ﹤0.01% 7701
2014
Q3 		– Sell
-25,805
Closed -$654K – 10095
2014
Q2 		$649K Buy
+25,805
New +$601K ﹤0.01% 6964
2014
Q1 		– Sell
-11,200
Closed -$310K – 9578
2013
Q4 		$299K Sell
11,200
-5,547
-33% -$137K ﹤0.01% 7580
2013
Q3 		$319K Buy
+16,747
New +$383K ﹤0.01% 7113

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's ABMD Position: Q4 2022 in Review

Susquehanna International Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 971 shares — an estimated $239K sold.

Susquehanna International Group first reported a position in ABMD in Q3 2013 and held it in 34 quarters. The position peaked at $29.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Susquehanna International Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 971 Abiomed Inc shares in Q4 2022, an estimated $239K.
  • Susquehanna International Group first reported a position in Abiomed Inc in Q3 2013 and held it in 34 quarters.
  • Susquehanna International Group's Abiomed Inc position peaked at $29.9M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.